You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • FRI0232 Consistent efficacy and safety outcomes between european and japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study

Citation Tools

Article menu
Download PDFPDF
Poster Presentation
Rheumatoid arthritis - other biologic treatment
FRI0232 Consistent efficacy and safety outcomes between european and japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Burmester G, Takeuchi T, Barbarash O, et al
FRI0232 Consistent efficacy and safety outcomes between european and japanese subjects with rheumatoid arthritis following treatment with mavrilimumab in the phase 2 earth study
Annals of the Rheumatic Diseases 2013;72:A451-A452.